Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Milosevic-Ðordevic, O.
Right arrow Articles by Bankovic, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milosevic-Ðordevic, O.
Right arrow Articles by Bankovic, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 18, No. 2, 433-436, February 2003
© 2003 European Society of Human Reproduction and Embryology

Effect of various doses of gestogens on micronuclei frequency in human peripheral blood lymphocytes of pregnant women

Olivera Milosevic-Ðordevic1,4, Darko Grujicic1, Dragoslav Marinkovic2, Slobodan Arsenijevic3 and Smilja Bankovic3

1 Faculty of Science, Institute of Biology, Department of Genetics, University of Kragujevac, Radoja Domanovica 12, P.O. Box 60, 34000 Serbia, Kragujevac, 2 Faculty of Biology, Belgrade, and 3 Clinic of Gynecology, Kragujevac, Yugoslavia 4 To

whom To whom correspondence should be addressed. e-mail: olivera@knez.uis.kg.ac.yu

BACKGROUND: Since gestogens, in the form of hormonal substitution therapy, have been proposed to have a role in the prevention of threatened spontaneous abortions during the first three months of pregnancy, we decided to evaluate possible genotoxic effects of these preparations. METHODS: A total of 30 pregnant women, with a diagnosis of threatened spontaneous abortions, received the gestogen therapy in the first 3 months, and a sample of 30 pregnant women without indication for hormonal therapy were included as the control group. For investigation of mutagenic effects of gestogens in vivo the cytokinesis block (CB) micronucleus (MN) test was applied. RESULTS: Average MN frequency in the control group was 6.79 ± 0.69 MN/1000 cells. The second analysed group included 12 patients with threatened spontaneous abortions, who received gestogen therapy in doses of 100–750 mg. Average MN frequency in these patients before therapy was 11.83 ± 1.33 MN/1000 cells, and after therapy it was 16.50 ± 1.32 MN/1000 cells (P < 0.001). The third analysed group comprised nine patients, who received gestogen therapy in doses of 750–2000 mg. Average MN frequency in these patients before therapy was 15.67 ± 3.00 MN/1000 cells, and after therapy was 23.89 ± 2.49 MN/1000 cells (P < 0.001). The fourth analysed sample comprised nine patients, treated with gestogen doses of 2000–8400 mg. The average MN frequency in these patients before therapy was 11.89 ± 1.63 MN/1000 cells, and after therapy was 21.22 ± 2.80 MN/1000 cells (P < 0.001). CONCLUSIONS: The increase of therapeutic gestogen doses was followed by an increase of average MN frequency. The greatest rise of MN frequency (1.8-fold) was observed in the group of patients who were treated with the highest gestogen doses (2000–8400 mg). The smallest increase (1.4-fold) of MN frequency was found in the group of patients whose therapeutic doses were the lowest (100–750 mg).

Key words: genotoxicity/gestogens/micronuclei/peripheral blood lymphocytes/pregnancy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
S.-U. Chen, C.-Y. Chang, C.-C. Lu, F.-J. Hsieh, H.-N. Ho, and Y.-S. Yang
Microtubular spindle dynamics and chromosome complements from somatic cell nuclei haploidization in mature mouse oocytes and developmental potential of the derived embryos
Hum. Reprod., May 1, 2004; 19(5): 1181 - 1188.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.